AAAS inducts new members
The American Academy of Arts and Sciences has announced its 2022 inductees. The organization, founded in 1780, honors members who work in science, education, the arts and global affairs. Its members also meet to tackle problems such as accelerating climate action, improving the relationship between science and the public, and strengthening international research partnerships. Three of this year’s inductees are members of the American Society for Biochemistry and Molecular Biology: Mariano Garcia–Blanco, Rachel Klevit and Aviv Regev.

Mariano Garcia–Blanco is a professor and distinguished chair in biochemistry and molecular biology at the University of Texas Medical Branch at Galveston and an adjunct professor at the Duke–National University of Singapore Medical School. His lab is known for its research on RNA-binding proteins in infection and immunity. They have identified numerous RNA-binding proteins that affect the replication of flaviviruses such as dengue, yellow fever and Zika. They also have studied the role of RNA helicase DDX39B in alternative splicing of the interleukin 7 receptor, which affects some autoimmune disorders such as multiple sclerosis.
Garcia–Blanco earned his MD and Ph.D. at Yale University and was a postdoctoral researcher at the Massachusetts Institute of Technology. He has founded five companies and is a member of the Association of American Physicians and a fellow of the American Association for the Advancement of Science and the American Academy of Microbiology.

Rachel Klevit is a professor of biochemistry, with secondary appointments in pharmacology and chemistry, at the University of Washington. Her lab uses structural biology techniques including nuclear magnetic resonance and hydrogen-deuterium exchange mass spectrometry to characterize proteins involved in ubiquitylation and protein chaperone activity. They are interested in the E3 ligase domain of the protein BRCA1, mutations in which can predispose carriers to breast cancer, and the protein BARD1, which functions in tandem with BRCA1. They also study small heat shock proteins, with particular interest in disordered or "fuzzy" binding.
Klevit earned her D.Phil. on a Rhodes scholarship at Oxford University and was a postdoc at Duke University. Among her awards are the ASBMB's Fritz Lippmann Award and the Protein Society's Dorothy Crowfoot Hodgkin award; last year, she was elected to the National Academy of Sciences.

Aviv Regev is an executive vice president and head of Genentech Research and Early Development. Regev, a computational biologist, is known for her contributions to single-cell genomics. Her lab leads several major systems biology projects and has developed new experimental and computational methods for massively parallel RNA sequencing to understand cellular regulatory networks. She co-leads the Human Cell Atlas initiative with Sarah Teichmann.
Regev earned her Ph.D. at Tel Aviv University and was an independent Bauer fellow at Harvard University. Before transitioning to Genentech, she was a Howard Hughes Medical Institute investigator, a professor of biology at the Massachusetts Institute of Technology and a core member of the Broad Institute of MIT and Harvard. Among her many honors are the ASBMB's Earl and Thressa Stadtman award, the FASEB Excellence in Science Award and membership in both the National Academy of Sciences and the National Academy of Medicine.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

Fliesler wins scientific and ethical awards
He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.